lymphoma

By TARA COPP - Associated Press WASHINGTON (AP) — The Air Force has detected unsafe levels of a likely carcinogen at underground launch control centers at a Montana nuclear missile base where a…

BOSTON and SHANGHAI, China and LAUSANNE, Switzerland, July 24, 2023 (GLOBE NEWSWIRE) -- Overland ADCT BioPharma, a joint venture of Overland Pharmaceuticals (CY) Inc. and ADC Therapeutics SA (NYSE: ADCT), today announced that the China…

Abivertinib is a novel Bruton’s tyrosine kinase (BTK) inhibitor that irreversibly targets BTK. BTK inhibitors are a large category in cancer treatment, with multiple indications and generating over $10.6 billion per year revenue in 2022.In…

Newark, New Castle, USA, June 23, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the size of the global market for lymphoma treatment in 2022 to be worth US$ 9.76 billion and is expected to increase at a revenue CAGR of 8.9% to…

At the highest dose 4 out of 4 PTCL patients achieved a response using the original manufacturing process (Process A)Ongoing complete metabolic responses in 2 out of 4 patients at 15 and 18-months post-dosing at the highest dose…

Newark, New Castle, USA, June 15, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global intraocular lymphoma treatment market was conducted by Growth Plus Reports in 2022 and valued at US$ 1.02 billion. The market is expected to hit…

A pre-clinical data set of AFM13 in combination with Artiva Biotherapeutics Inc.’s allogeneic NK cell AB-101 shows that AFM13 enhances the cytotoxic activity of AB-101 against tumor cells and has been accepted for poster presentationAn…

Dennis Thompson TUESDAY, July 6, 2023 (HealthDay News) -- The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin…

Cara Murez FRIDAY, June 2, 2023 (HealthDay News) -- Not a lot is known about how physicians should handle cases in which a pregnant woman is diagnosed with relapsed/refractory lymphoma.A new…

New York, USA, May 31, 2023 (GLOBE NEWSWIRE) -- B-Cell Lymphoma Clinical Trial Pipeline Insights: DelveInsight Evaluates a Robust Pipeline as 160+ Influential Pharma Players to Set Foot in the Domain The prevalence of B-cell lymphoma…